HSA — authorised 1 February 2023
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: likely_approved
🇸🇬 Jesduvroq in Singapore
HSA authorised Jesduvroq on 1 February 2023
Marketing authorisation
Jesduvroq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Singapore
Frequently asked questions
Is Jesduvroq approved in Singapore?
Yes. HSA authorised it on 1 February 2023.
Who is the marketing authorisation holder for Jesduvroq in Singapore?
GLAXOSMITHKLINE holds the Singaporean marketing authorisation.